Back

Prognostic value of diffuse high-risk plaque in patients with acute myocardial infarction: a three-vessel optical coherence tomography study

1 September 2024 (09:00 - 09:50)
Organised by: Logo
Congress Presentation Part of: Imaging in acute coronary syndromes Imaging of Acute Coronary Syndromes ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Chao Fang

The Second Affiliated Hospital of Harbin Medical University, Harbin (China)

7 More presentations in this session

Presentation thumbnail
Mechanical wave velocities in acute myocardial infarction: an exploratory study using three-dimensional high frame rate echocardiography
Ms M. Halvorsrod (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
One-year prognostic value of right ventricular to pulmonary arterial coupling in patients hospitalized for acute coronary syndrome: insights from the ADDICT-ICCU study
Doctor C. Nogarede (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Predictors of hypercontractile heart phenotype in patients with chronic coronary syndromes
Ms Y. WANG (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Impact of coronary revascularization on clinical outcomes of post-acute myocardial infarction patients with left ventricular thrombus
Doctor A. Seah (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Mechanical wave velocities by clutter filter wave imaging detects myocardial dysfunction in acute coronary syndrome
Doctor K. Andresen (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

1 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Plaque characteristics and long-term outcome of non-culprit plaque rupture in AMI patients
thumbnail
Congress Presentation
Long-term prognostic value of optical coherence tomography-identified non-culprit plaque rupture
thumbnail
Congress Session
Optical coherence tomography and cardiovascular risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources